期刊文献+

药动学-药效学模型与效应室目标控制输注 被引量:2

下载PDF
导出
摘要 药动学-药效学模型是将药代动力学模型和药效动力学模型有机地结合起来,研究药物剂量与药物效应之间的 定量关系。其中效应室消除速率常数(ke0)是重要的模型参数.描述药物在中央室和效应室之间平衡的快慢,也是效应室目标 控制输注的重要参数。效应室目标控制输注比血药浓度目标控制输注的起效时间更短,而副作用并不明显增加。
作者 刘荣 曾邦雄
出处 《国外医学(麻醉学与复苏分册)》 CAS 2001年第6期331-333,共3页 Foreign Medical Sciences(Anesthesilolgy and Resuscitation)
  • 相关文献

参考文献14

  • 1Sheiner LB et al. Chin Pharmacol Ther, 1979; 25: 358
  • 2Shafer SL et al. J Pharmacokinet Biopharm, 1992; 20: 147
  • 3Fisher DM et al. Anesthesiology, 1997;86:567
  • 4Sebel PS et al. AnesthAnalg,1997;84:891
  • 5Doi M et al. Br J Anaesth,1998;80:46
  • 6Schnider TW et al. Anesthesiology, 1999; 90: 1502
  • 7Struys M et al. Anesthesiology,2000;92:399
  • 8Jacobs JR et al. IEEE Trans Biomed Eng,1993:40:993
  • 9刘荣,招伟贤,徐世元,叶小平,许睿.固定或改变目标浓度的普鲁泊福目标控制输注的性能[J].中国药理学通报,2000,16(1):111-114. 被引量:3
  • 10Struys M et al. Anaesthesia,1998;53:4

二级参考文献9

共引文献2

同被引文献20

  • 1师少军,顾世芬,陈汇,曾繁典.蝙蝠葛碱在犬体内的药代动力学和药效动力学研究[J].中国药理学通报,2005,21(4):464-467. 被引量:14
  • 2黄晓晖,裘福荣,李俊.厄贝沙坦在健康志愿者体内的药代动力学-药效学结合模型[J].中国药理学通报,2005,21(6):712-715. 被引量:8
  • 3Gunnar Alv án,Gilles Paintaud,Monique Wakelkamp.The Efficiency Concept in Pharmaco-dynamics[J].Clin Pharmacokinet.1999,36(5):375-389.
  • 4Hartmut Derendorf and Bernd Meibohm.Modeling of Pharmacokinetic/Pharmacody (PK/PD) Relationships:Concepts and Perspectives[J].Pharmaceutical Research,1999,16(2):176-184.
  • 5Johan L Gabrielsson,Daniel L Weiner.Methodology for pharmacokinetic/phar-macodynamic data analysis[J].PSTT,1999,2(6):244-252.
  • 6Jo" rn Lo" tsch.Pharmacokinetic-Pharmacodynamic Modeling of Opioids[J].Journal of Pain and Symptom Management,2005,29(55):90-103.
  • 7Anna Ollerstam,Sandra A.G.Visser,Anna H.Persson,et al.parmacokinetic-pharmacodynamic modeling of drug-induced effect on the QT interval in conscious telemetered dogs[J].Journal of Pharmacological and Toxicological Methods,2005,7(20):1-10.
  • 8Yang RS,Thomas RS,Gustafson DL.Approaches to developing alternative and predictive toxicology based on PB PK/PD and QSAR modeling[J].Environ Health Perspect,1998,106(8):1385-1393.
  • 9Daniel D.Gretler,Roberto Guerciolini,Paul J.Williams.Pharmacokinetic and Pharmaco-dynamic Properties of Eptifibatide in Subjects with Normal or Impaired Renal Function[J].Clinical Therapeutics,2004,26(3):390-398.
  • 10Mari Tsuchihashi,Hideyoshi Harashima,Hiroshi Kiwada.Development of a pharmacokinetic/pharmacodynamic(PK/PD)-simulation system for doxorubicin in long circulating liposomes in mice using peritoneal P388[J].Journal of Controlled Release,1999,61(11):9-19.

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部